Big Gain For MacroGenics, Inc.

Tue, Mar 10, 2026 at 07:25 PM

MacroGenics, Inc. (MGNX:NASDAQ) rocketted at $3.43, a gain of 45.3%. On Tue, Mar 10, 2026, MGNX:NASDAQ hit a New 2-Week High of $3.43. The stock got featured on our News Catalysts scanner on Mon, Mar 09, 2026 at 06:36 PM in the 'EARNINGS' category. From Tue, Feb 24, 2026, the stock recorded 80.00% Up Days and 90.91% Green Days

About MacroGenics, Inc. (MGNX:NASDAQ)

Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.

Top 10 Gainers:

Agape ATP Corporation (ATPC:NASDAQ), 87.13%
Polaryx Therapeutics Inc. (PLYX:NASDAQ), 69.6%
Longeveron Inc. (LGVN:NASDAQ), 68.27%
Decent Holding Inc. (DXST:NASDAQ), 50.42%
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 48.34%
MacroGenics, Inc. (MGNX:NASDAQ), 45.34%
Nauticus Robotics, Inc. (KITT:NASDAQ), 42.46%
Zenvia Inc. (ZENV:NASDAQ), 41.33%
N2OFF, Inc. (NITO:NASDAQ), 38.64%
Murano Global Investments Plc (MRNO:NASDAQ), 38.08%